RecruitingPhase 4NCT05839652

Treatment of Orthostatic Hypotension in SCI

Treatment of Orthostatic Hypotension in Individuals With Spinal Cord Injury


Sponsor

James J. Peters Veterans Affairs Medical Center

Enrollment

25 participants

Start Date

Jul 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Midodrine Hydrochloride for people with hypotension. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMidodrine Hydrochloride

Determine best drug and dose to increase and stabilize SBP during orthostatic tilt


Locations(2)

Kessler Foundation

West Orange, New Jersey, United States

James J Peters VA Medical Center

The Bronx, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05839652


Related Trials